CN Patent

CN102159214A — 用于实体肿瘤的治疗的布鲁顿酪氨酸激酶的抑制剂

Assigned to Pharmacyclics LLC · Expires 2011-08-17 · 15y expired

What this patent protects

本发明在此描述的是不可逆的Btk抑制剂化合物，在特征在于实体肿瘤的存在或发展的疾病和病症的治疗中使用这样的不可逆抑制剂的方法。

USPTO Abstract

本发明在此描述的是不可逆的Btk抑制剂化合物，在特征在于实体肿瘤的存在或发展的疾病和病症的治疗中使用这样的不可逆抑制剂的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN102159214A
Jurisdiction: CN
Classification: —
Expires: 2011-08-17
Drug substance claim: No
Drug product claim: No
Assignee: Pharmacyclics LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.